Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013)

Author： Song Heng Ao Gui-Zhen Li Huan-Qiu

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.24, Iss.1, 2014-01, pp. : 19-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel FabH inhibitors: a patent and article literature review (2000 – 2012)

By Luo Yin Yang Yu-Shun Fu Jie Zhu Hai-Liang

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1325-1336

Informa Healthcare

Access to resources Recommend Favorite

Advances in the Research of &bgr;-Ketoacyl-ACP Synthase III (FabH) Inhibitors

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1225-1237

Bentham Science Publishers

Access to resources Recommend Favorite

Bacterial &bgr;-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) as a Target for Novel Antibacterial Agents Design

Current Medicinal Chemistry, Vol. 22, Iss. 5, 2015-02 ,pp. : 651-667

Bentham Science Publishers

Access to resources Recommend Favorite

p38 MAPK inhibitors: a patent review (2012 – 2013)

By Bühler Stefanie Laufer Stefan A

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 535-554

Informa Healthcare

Access to resources Recommend Favorite

Major Pharmaceutical Conferences and Courses: June to July 2012

Pharmaceutical Medicine, Vol. 26, Iss. 2, 2012-04 ,pp. : 141-143

Adis International

Access to resources Recommend Favorite